Newtyn Management’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-960,000
| Closed | -$1.74M | – | 50 |
|
|
2023
Q1 | $1.74M | Buy |
960,000
+360,000
| +60% | +$652K | 0.34% | 50 |
|
|
2022
Q4 | $1.6M | Buy |
600,000
+130,000
| +28% | +$346K | 0.33% | 41 |
|
|
2022
Q3 | $1.56M | Hold |
470,000
| – | – | 0.34% | 44 |
|
|
2022
Q2 | $1.71M | Buy |
470,000
+219,864
| +88% | +$800K | 0.32% | 47 |
|
|
2022
Q1 | $1.27M | Buy |
250,136
+5,000
| +2% | +$25.4K | 0.3% | 35 |
|
|
2021
Q4 | $1.87M | Hold |
245,136
| – | – | 0.5% | 32 |
|
|
2021
Q3 | $3.63M | Sell |
245,136
-10,000
| -4% | -$148K | 0.97% | 28 |
|
|
2021
Q2 | $3.61M | Buy |
+255,136
| New | +$3.61M | 1% | 24 |
|